Lucio N. Gordan, MDChief Medical Officer of Therapeutics and Analytics
Dr. Lucio Gordan earned his medical degree from the State University of Londrina College of Medicine in Londrina, Brazil, and later completed his internship and residency at the University of Iowa Hospitals & Clinics. After finishing his residency, Dr. Gordan was awarded a fellowship in Medical Oncology/Hematology at the University of Florida, Gainesville, FL. He is Board-certified in Medical Oncology, Hematology, and Internal Medicine.
Currently, Dr. Gordan serves as Chief Medical Officer for Therapeutics and Analytics at Florida Cancer Specialists & Research Institute (FCS) and practices at the FCS Gainesville Cancer Center. He also serves as a member of the board of directors for Community Oncology Alliance (COA), Florida Association of Clinical Oncology (FLASCO), National Cancer Oral Dispensing Association (NCODA) and FCS.
As a cancer researcher and the recipient of research grants, Dr. Lucio Gordan is actively engaged in early and late clinical trials. His work has been published in several peer-reviewed journals. He serves in the editorial board of several oncology journals. Dr. Gordan is currently in charge of the development of Digital FCS, real world evidence division at FCS, therapeutics decisions, dynamic decision-support tool among other tasks. He is immediate past President of FCS. In 2013, Dr. Gordan was awarded the prestigious FRIST Award from the Hospital Corporation of America (HCA) in recognition of his service in the Gainesville community. He is the co-chair of Humanitarian Initiatives at COA supporting national and international crisis.
Frequently, he participates in national and international meetings as a speaker and key thought leader. Married and the father of one child, Dr. Gordan enjoys traveling, reading, working in his horse farm and photography.
- Medical Oncologist
- State University of Londrina College of Medicine | Londrina, State of Paraná, Brazil
- University of Iowa Hospitals and Clinics | Iowa City, IA
- University of Florida | Gainesville, Florida
- Medical Oncology
- Internal Medicine
- American Medical Association (AMA)
- American Society of Clinical Oncology (ASCO)
- American Society of Hematology (ASH)
- Community Oncology Alliance (COA)
- Florida Society of Clinical Oncology (FLASCO)
Journal of Clinical Pathways spoke with Lucio N Gordan, MD, medical director in the division of quality and informatics, Florida Cancer Specialists and Research Institute, regarding his recent report for the Community Oncology Alliance and the implications that setting has on cost of cancer for patients.